Hard nut to crack: new trial brings new hope for children with peanut allergies

The Allergen Research Corporation was born, and two Phase II trials and a name change later, Aimmune Therapeutics is now well on the way to meeting its original goal. Credit: Courtesy of Aimmune Therapeutics